東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Linked to FindBook

Google Book

Amazon

博客來

Investigating the Mechanisms and Kinetics of Circulating Tumour DNA Release to Improve Its Clinical Utility.

Record Type:	Electronic resources : Monograph/item
Title/Author:	Investigating the Mechanisms and Kinetics of Circulating Tumour DNA Release to Improve Its Clinical Utility./
Author:	Rostami, Ariana.
Published:	Ann Arbor : ProQuest Dissertations & Theses, : 2021,
Description:	157 p.
Notes:	Source: Dissertations Abstracts International, Volume: 83-01, Section: B.
Contained By:	Dissertations Abstracts International83-01B.
Subject:	Molecular biology. -
Online resource:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=28261840
ISBN:	9798522942847

Investigating the Mechanisms and Kinetics of Circulating Tumour DNA Release to Improve Its Clinical Utility.
Rostami, Ariana.

Investigating the Mechanisms and Kinetics of Circulating Tumour DNA Release to Improve Its Clinical Utility. - Ann Arbor : ProQuest Dissertations & Theses, 2021 - 157 p.

Source: Dissertations Abstracts International, Volume: 83-01, Section: B.

Thesis (Ph.D.)--University of Toronto (Canada), 2021.

This item must not be sold to any third party vendors.

Head and neck squamous cell carcinoma (HNSCC) is a heterogeneous disease with distinct subtypes, molecular features and clinical behaviours. Significant advances to better define this heterogeneity have revealed new targets and attempted to stratify patients into clinically meaningful groups. Human papillomavirus (HPV)-positive HNSCC has been recognized as a distinct etiology with significantly better treatment response and overall survival compared to HPV-negative HNSCC. However, despite the improved prognosis of these patients, current therapies result in significant toxicities, and subtype-specific treatments are still lacking. Thus, there remains an urgent need for additional biomarkers of therapeutic sensitivity to better risk stratify these patients and enable personalized treatment regimens. Circulating tumour DNA (ctDNA) has sparked tremendous interest in the last decade as a non-invasive method to monitor dynamic changes in treatment response. However, the mechanisms that dictate ctDNA release kinetics have not been thoroughly investigated, hampering the interpretation of such ctDNA kinetic patterns. To address this gap, I first evaluated the biological underpinnings that dictate ctDNA release using preclinical models of HNSCC. To evaluate the generalizability of my findings, I simultaneously evaluated ctDNA release from other cell types including mesenchymal cells and lung adenocarcinoma. Through detailed mechanistic studies, I uncovered a complex interplay between apoptosis, necrosis and senescence in determining ctDNA release kinetics, where treatment type and timing from treatment exposure were key factors influencing release. I next investigated the longitudinal kinetics of ctDNA release in 70 HNSCC patients treated with definitive radiotherapy or chemoradiotherapy. Three patterns of ctDNA kinetics were observed, with HNSCC patients exhibiting frequent on-treatment spikes, with a strong dependence on treatment type. Lastly, utilizing the knowledge gained in regard to the underlying biology and longitudinal profiles of ctDNA release, I identified a cohort of 235 HPV-positive oropharyngeal carcinoma patients and discussed the next steps in evaluating the relationship between ctDNA kinetic changes and clinical response. These studies provide novel insights into the biological mechanisms and dynamic changes of treatment-induced ctDNA release. Overall, these findings highlight the potential clinical utility of dynamic ctDNA monitoring to facilitate biomarker-driven adaptive therapy, with the intent to maximize disease control and minimize current treatment related-morbidities.

ISBN: 9798522942847Subjects--Topical Terms:

517296
Molecular biology.
Subjects--Index Terms:

Cell death

Investigating the Mechanisms and Kinetics of Circulating Tumour DNA Release to Improve Its Clinical Utility.
LDR:03904nmm a2200397 4500 001 2343814
005 20220513114325.5
008 241004s2021 ||||||||||||||||| ||eng d
020 $a 9798522942847
035 $a (MiAaPQ)AAI28261840
035 $a AAI28261840
040 $a MiAaPQ $c MiAaPQ
100 1 $a Rostami, Ariana. $3 3682466
245 1 0 $a Investigating the Mechanisms and Kinetics of Circulating Tumour DNA Release to Improve Its Clinical Utility.
260 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2021
300 $a 157 p.
500 $a Source: Dissertations Abstracts International, Volume: 83-01, Section: B.
500 $a Advisor: Bratman, Scott.
502 $a Thesis (Ph.D.)--University of Toronto (Canada), 2021.
506 $a This item must not be sold to any third party vendors.
520 $a Head and neck squamous cell carcinoma (HNSCC) is a heterogeneous disease with distinct subtypes, molecular features and clinical behaviours. Significant advances to better define this heterogeneity have revealed new targets and attempted to stratify patients into clinically meaningful groups. Human papillomavirus (HPV)-positive HNSCC has been recognized as a distinct etiology with significantly better treatment response and overall survival compared to HPV-negative HNSCC. However, despite the improved prognosis of these patients, current therapies result in significant toxicities, and subtype-specific treatments are still lacking. Thus, there remains an urgent need for additional biomarkers of therapeutic sensitivity to better risk stratify these patients and enable personalized treatment regimens. Circulating tumour DNA (ctDNA) has sparked tremendous interest in the last decade as a non-invasive method to monitor dynamic changes in treatment response. However, the mechanisms that dictate ctDNA release kinetics have not been thoroughly investigated, hampering the interpretation of such ctDNA kinetic patterns. To address this gap, I first evaluated the biological underpinnings that dictate ctDNA release using preclinical models of HNSCC. To evaluate the generalizability of my findings, I simultaneously evaluated ctDNA release from other cell types including mesenchymal cells and lung adenocarcinoma. Through detailed mechanistic studies, I uncovered a complex interplay between apoptosis, necrosis and senescence in determining ctDNA release kinetics, where treatment type and timing from treatment exposure were key factors influencing release. I next investigated the longitudinal kinetics of ctDNA release in 70 HNSCC patients treated with definitive radiotherapy or chemoradiotherapy. Three patterns of ctDNA kinetics were observed, with HNSCC patients exhibiting frequent on-treatment spikes, with a strong dependence on treatment type. Lastly, utilizing the knowledge gained in regard to the underlying biology and longitudinal profiles of ctDNA release, I identified a cohort of 235 HPV-positive oropharyngeal carcinoma patients and discussed the next steps in evaluating the relationship between ctDNA kinetic changes and clinical response. These studies provide novel insights into the biological mechanisms and dynamic changes of treatment-induced ctDNA release. Overall, these findings highlight the potential clinical utility of dynamic ctDNA monitoring to facilitate biomarker-driven adaptive therapy, with the intent to maximize disease control and minimize current treatment related-morbidities.
590 $a School code: 0779.
650 4 $a Molecular biology. $3 517296
650 4 $a Cellular biology. $3 3172791
650 4 $a Oncology. $3 751006
650 4 $a Biophysics. $3 518360
650 4 $a DNA methylation. $3 3560639
650 4 $a Mutation. $3 837917
650 4 $a Chromosomes. $3 638948
650 4 $a Apoptosis. $3 600650
650 4 $a Cell growth. $3 3560747
650 4 $a Human papillomavirus. $3 3682467
650 4 $a Kinases. $3 3558077
653 $a Cell death
653 $a Circulating cell-free DNA
653 $a Circulating tumour DNA
653 $a Head and neck cancer
653 $a Liquid biopsy
653 $a Treatment monitoring
690 $a 0307
690 $a 0786
690 $a 0379
690 $a 0992
710 2 $a University of Toronto (Canada). $b Medical Biophysics. $3 3181600
773 0 $t Dissertations Abstracts International $g 83-01B.
790 $a 0779
791 $a Ph.D.
792 $a 2021
793 $a English
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=28261840